Search alternatives:
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
blind decrease » ligand decrease (Expand search), and decrease (Expand search), skins decrease (Expand search)
decrease after » increase after (Expand search), disease after (Expand search)
decrease akt » decrease at (Expand search), decrease and (Expand search), decrease with (Expand search)
akt decrease » and decrease (Expand search), not decrease (Expand search), any decrease (Expand search)
single blind » single and (Expand search)
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
blind decrease » ligand decrease (Expand search), and decrease (Expand search), skins decrease (Expand search)
decrease after » increase after (Expand search), disease after (Expand search)
decrease akt » decrease at (Expand search), decrease and (Expand search), decrease with (Expand search)
akt decrease » and decrease (Expand search), not decrease (Expand search), any decrease (Expand search)
single blind » single and (Expand search)
1
“... with sumatriptan have demonstrated efficacy in reducing recurrence observed with the single use of this...”
Access document
Access document
Article
2
“...: Double-blind, placebo-controlled, single-center study (NCT03467282), adult NASH, randomized for 24 weeks...”
Access document
Access document
Article
3
“.... Fourteen females were assigned to daily or weekly doses of LT4. After six weeks, they switched regimens...”
Access document
Access document
Article
4
“... cryotherapeutic preparations. Design: Randomised, single-blind, crossover trial. Setting: University laboratory...”
Access document
Access document
Article
5
6
“... of pyridostigmine (PYR), a reversible acetylcholinesterase inhibitor. METHODS: A double-blind, randomized, cross...”
Access document
Access document
Article
7
8
“... de sinalização EGFR/ PI3K/ AKT/ mTOR que está relacionada a processos biológicos de sobrevivência e crescimento...”
Access document
Access document
Bachelor thesis
9
10
11
12
13
14
15
“... on infection rates in patients undergoing SARME. A randomized, double-blind clinical trial was carried out with...”
Access document
Access document
Article
16
“... perfusion was assessed eight hours after drug administration by means of single photon emission tomography...”
Access document
Access document
Article
17
18
“... the diagnosis of heart failure (HF) were selected for this double-blind, crossover type clinical trial...”
Access document
Access document
Article
19
20